Publications
Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib.
January 1st, 2019
R.J. LaCount
Publications
January 1st, 2019
R.J. LaCount
Modal Content
We're using cookies to deliver you the best user experience. Learn More